Crowd-sourced symptom data in pollen allergy: testing a novel study approach for assessing the efficacy of food supplements

Lukas Dirr, Katharina Bastl, Maximilian Bastl, Johannes M. Bouchal, Uwe E. Berger, Friðgeir Grímsson
{"title":"Crowd-sourced symptom data in pollen allergy: testing a novel study approach for assessing the efficacy of food supplements","authors":"Lukas Dirr,&nbsp;Katharina Bastl,&nbsp;Maximilian Bastl,&nbsp;Johannes M. Bouchal,&nbsp;Uwe E. Berger,&nbsp;Friðgeir Grímsson","doi":"10.1007/s40629-024-00283-y","DOIUrl":null,"url":null,"abstract":"<p>Pollen allergy can have a significant impact on a person’s quality of life. Recently, food supplements have gained in importance for persons suffering from pollen allergy. Still, there is not much research data on the efficacy of food supplements and the experienced relief, especially when choosing study designs that require less effort than randomized controlled trials (RCT).</p><p>A food supplement containing an <i>Astragalus membranaceus</i> root extract was administered to 328 voluntary participants during the 2018 birch, grass and ragweed pollen season in Austria. Participants documented their symptoms and medication intake in the online Patients Hay-fever Diary (PHD). All participants were asked to answer a quality-of-life questionnaire at the end of the study. Alongside with the adherence rate the overall symptom load index (SLI) and the nasal symptoms of the participants were monitored and compared to a filtered group of users from the PHD.</p><p>The adherence rates range from 32.8% to 77.3%. Additional data like a quality-of-life questionnaire and the mean overall/nasal SLI showed differences between participants and the baseline. However, they were only statistically significant for the ragweed pollen season and the nasal symptoms.</p><p>The study design relied on the evaluation of crowd-source symptom data alone by comparing the participants with a baseline. The participant adherence turned out lower than expected; however a trend for reduced symptoms was found and is also supported by the quality-of-life questionnaire.</p>","PeriodicalId":37457,"journal":{"name":"Allergo Journal International","volume":"33 6","pages":"180 - 189"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s40629-024-00283-y.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergo Journal International","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1007/s40629-024-00283-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Pollen allergy can have a significant impact on a person’s quality of life. Recently, food supplements have gained in importance for persons suffering from pollen allergy. Still, there is not much research data on the efficacy of food supplements and the experienced relief, especially when choosing study designs that require less effort than randomized controlled trials (RCT).

A food supplement containing an Astragalus membranaceus root extract was administered to 328 voluntary participants during the 2018 birch, grass and ragweed pollen season in Austria. Participants documented their symptoms and medication intake in the online Patients Hay-fever Diary (PHD). All participants were asked to answer a quality-of-life questionnaire at the end of the study. Alongside with the adherence rate the overall symptom load index (SLI) and the nasal symptoms of the participants were monitored and compared to a filtered group of users from the PHD.

The adherence rates range from 32.8% to 77.3%. Additional data like a quality-of-life questionnaire and the mean overall/nasal SLI showed differences between participants and the baseline. However, they were only statistically significant for the ragweed pollen season and the nasal symptoms.

The study design relied on the evaluation of crowd-source symptom data alone by comparing the participants with a baseline. The participant adherence turned out lower than expected; however a trend for reduced symptoms was found and is also supported by the quality-of-life questionnaire.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
花粉过敏的众包症状数据:测试评估食物补充剂功效的新型研究方法
花粉过敏会严重影响患者的生活质量。最近,食物补充剂对花粉过敏患者的重要性日益凸显。然而,关于食物补充剂的疗效和缓解效果的研究数据仍然不多,尤其是在选择比随机对照试验(RCT)更省力的研究设计时。在奥地利的2018年桦树、草和豚草花粉季节,328名自愿参与者服用了含有黄芪根提取物的食物补充剂。参与者在在线 "花粉热患者日记"(PHD)中记录了自己的症状和药物摄入情况。研究结束时,所有参与者都被要求回答一份生活质量问卷。除了坚持用药率外,还对参与者的总体症状负荷指数(SLI)和鼻腔症状进行了监测,并与从 PHD 中筛选出的一组用户进行了比较。生活质量调查问卷和总体/鼻腔SLI平均值等其他数据显示,参与者与基线之间存在差异。然而,这些差异仅在豚草花粉季节和鼻部症状方面具有统计学意义。研究设计通过将参与者与基线进行比较,仅对人群源症状数据进行评估。参与者的坚持率低于预期,但发现了症状减轻的趋势,生活质量调查问卷也证实了这一点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Allergo Journal International
Allergo Journal International Medicine-Immunology and Allergy
CiteScore
4.60
自引率
0.00%
发文量
31
期刊介绍: Allergo Journal International is the official Journal of the German Society for Applied Allergology (AeDA) and the Austrian Society for Allergology and Immunology (ÖGAI). The journal is a forum for the communication and exchange of ideas concerning the various aspects of allergy (including related fields such as clinical immunology and environmental medicine) and promotes German allergy research in an international context. The aim of Allergo Journal International is to provide state of the art information for all medical and scientific disciplines that deal with allergic, immunological and environmental diseases. Allergo Journal International publishes original articles, reviews, short communications, case reports, and letters to the editor. The articles cover topics such as allergic, immunological and environmental diseases, the latest developments in diagnosis and therapy as well as current research work concerning antigens and allergens and aspects related to occupational and environmental medicine. In addition, it publishes clinical guidelines and position papers approved by expert panels of the German, Austrian and Swiss Allergy Societies. All submissions are reviewed in single-blind fashion by at least two reviewers. Originally, the journal started as a German journal called Allergo Journal back in 1992. Throughout the years, English articles amounted to a considerable portion in Allergo Journal. This was one of the reasons to extract the scientific content and publish it in a separate journal. Hence, Allergo Journal International was born and now is the international continuation of the original German journal. Nowadays, all original content is published in Allergo Journal International first. Later, selected manuscripts will be translated and published in German and included in Allergo Journal.
期刊最新文献
Requirements for regulatory acceptance of biomarkers Impact of obesity on allergic respiratory diseases and on mental and cognitive performance One health: the impact of environment, detergents and hygiene on barrier, microbiome and allergy Discharge management after anaphylaxis The role of IgG1 and IgG4 as dominant IgE-blocking antibodies during allergen immunotherapy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1